// App-Quantinova.ai

984 : IGF-1 levels are associated with CSF pathology and executive dysfunction in de novo Parkinson’s disease patients

Researchers

Presenter

  • G. Dervenoulas

Principal Investigators

  • G. Pagano

  • F. Niccolini

  • M. Politis

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Executive dysfunction

  • Parkinson's disease

Biomarkers

  • Insulin-like growth factor 1

  • Cerebrospinal fluid

Drug/Treatment

  • Mecasermin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved